TONON, GIOVANNI
 Distribuzione geografica
Continente #
EU - Europa 586
NA - Nord America 580
AS - Asia 73
AF - Africa 6
OC - Oceania 5
Totale 1.250
Nazione #
US - Stati Uniti d'America 579
SE - Svezia 391
IT - Italia 128
CN - Cina 37
FI - Finlandia 19
SG - Singapore 19
IE - Irlanda 14
DE - Germania 12
IN - India 8
NL - Olanda 7
CM - Camerun 5
GB - Regno Unito 5
AU - Australia 4
FR - Francia 3
ID - Indonesia 2
IR - Iran 2
MK - Macedonia 2
RU - Federazione Russa 2
TR - Turchia 2
TW - Taiwan 2
BW - Botswana 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PL - Polonia 1
RO - Romania 1
SI - Slovenia 1
Totale 1.250
Città #
Ashburn 140
Lawrence 139
Princeton 139
Milan 74
Shanghai 29
Boardman 26
New York 25
Helsinki 15
Singapore 15
Dublin 14
Seattle 9
Segrate 8
Pune 7
Los Angeles 6
Washington 6
Amsterdam 5
Bologna 4
Elsternwick 4
Lappeenranta 4
Sheffield 4
Bergamo 3
Framingham 3
Ingolstadt 3
Rome 3
Somma Lombardo 3
Trento 3
Brembate di Sopra 2
Carrara 2
Cittadella 2
Dijon 2
Parma 2
Skopje 2
Vaprio d'Adda 2
Zola Predosa 2
Acerra 1
Andover 1
Ankara 1
Baltimore 1
Bekasi 1
Cambridge 1
Castello di Cisterna 1
Cluj-Napoca 1
Coimbatore 1
Dearborn 1
Gaborone 1
Genoa 1
Gustavo Adolfo Madero 1
Hanover 1
Houston 1
Izmir 1
Legnano 1
Ljubljana 1
Manila 1
Mountain View 1
Naaldwijk 1
Nuremberg 1
Orlando 1
Oxford 1
Palermo 1
Pinehaven 1
Redwood City 1
Richmond 1
Tehran 1
Udine 1
Totale 737
Nome #
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 36
Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin 35
Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr701 phosphorylation 31
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia 23
PROFILING THE MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA AT RELAPSE AFTER CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 22
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches. 21
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation 19
Chest CT in the emergency department for suspected COVID-19 pneumonia 19
A "static" karyotype in epithelial cancer cell lines despite ongoing chromsomal instability 18
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 17
C-Myc- Dependent Stabilization of Hif-1alpha in MM: Therapeutic Implications 17
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment 15
Modeling Multiple Myeloma-Bone Marrow interactions and response to drugs in a 3D surrogate microenvironment 15
Tumor suppressor PNRC1 blocks rRNA maturation by recruiting the decapping complex to the nucleolus 15
Che-1-induced inhibition of mTOR pathway enables stress-induced autophagy 15
A next generation sequencing study in Italian multiplex families with multiple sclerosis 15
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection 14
Author Correction: Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr701 phosphorylation (Scientific Reports, (2020), 10, 1, (16906), 10.1038/s41598-020-73835-1) 14
K-ras activation generates an inflammatory response in lung tumors 14
Iron increases the susceptibility of multiple myeloma cells to bortezomib 13
CS1, a new surface target on multiple myeloma (MM) cells, protects myeloma cells from apoptosis via-regulation of ERKI/2, AKT and STAT3 signaling cascades 13
Loss of ribonuclease DIS3 hampers genome integrity in myeloma by disrupting DNA:RNA hybrid metabolism 12
Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma 12
Early onset sporadic colorectal cancer: Worrisome trends and oncogenic features 12
An Oncogene-Regulated Epigenetic Switch in T Cell Acute Lymphoblastic Leukemia 12
H3K4me3 demethylation by the histone demethylase KDM5C/JARID1C promotes DNA replication origin firing 12
Somatic mutations affect key pathways in lung adenocarcinoma 12
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression 11
Analyzing genomic and epigenetic profiles in single cells by hybrid transposase (scGET-seq) 11
MSH6 gene pathogenic variant identified in familial pancreatic cancer in the absence of colon cancer 11
STK4 inhibitors for treatment of hematological malignancies 11
Karotypic complexity of the "NCI-60" drug-screening panel 11
A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands 11
C-jun and C-ABL in human multiple myeloma cell death 11
Genetic distance, transportation costs, and trade 11
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies 10
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study 10
Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer 10
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival 10
Chromogranin A is preferentially cleaved into pro-angiogenic peptides in the bone marrow of multiple myeloma patients 10
Karyotypic "state" as a potential determinant for anticancer drug discovery. 10
Bone Marrow Endosteal Mesenchymal Progenitors Depend on HIF Factors for Maintenance and Regulation of Hematopoiesis 10
Loss of the histone demethylase UTX alters the gene expression prolife and contributes to the malignant phenotype of multiple myeloma cells 10
Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients 10
Novel Targets in Multiple Myeloma and Other Disorders 10
t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway 10
Deletion of a pseudogene within a fragile site triggers the oncogenic expression of the mitotic CCSER1 gene 10
Profiling the Genomic Landscape at the Early Stages of CLL: Low Genomic Complexity and Paucity of Driver Mutations in MBL and Indolent CLL 10
Plasma homocysteine levels in 10 patients with polycythemia. 10
Karyotypic complexity of the NCI-60 drug-screening panel. 10
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. 10
The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation 9
Lymphoma/myeloma 9
JunB/AP-1 controls MM cell proliferation, survival and drug resistance in the bone marrow microenvironment 9
UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition 9
Targeting PKC informs in MM by enzastaurin (LY317615.HCL) 9
Awakening the Hippo co-activator YAP1, a mercurial cancer gene, in hematologic cancers 9
Compositions, Kits, and Methods for identification, assessment, prevention, and therapy of cancer 9
Detection of MECT1-MAML2 fusion products 9
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets 9
HIGH-THROUGHPUT SEQUENCING FOR THE IDENTIFICATION OF DIS3 MUTATIONS IN MULTIPLE MYELOMA 9
Angiogenesis Associated with Alterations of the Bone Marrow Microenvironment Predicts Multiple Myeloma Progression to Symptomatic Disease in Mice and Humans 9
Targeting Mcl-1 for multiple myeloma (MM) therapy: Drug-induced generation of Mcl-1 fragment Mcl-1128-350 triggers MM cell death via c-Jun upregulation 9
The MEK1/2 inhibitor AZD6244 (ARRY-142886) downregulates constitutive and adhesion-induced c-MAF oncogene expression and its downstream targets in human multiple myeloma 9
TARGETING ANGIOGENESIS VIA A C-MYC/HIF-1 alpha-DEPENDENT PATHWAY IN MM 9
Weak platelet agonists and U46619 induce apoptosis-like events in platelets, in the absence of phosphatidylserine exposure. 9
INHIBITION OF THE STK4 KINASE RESTORES THE HIPPO CO-FACTOR YAP1 AND INDUCES DNA-DAMAGE MEDIATED APOPTOSIS IN MULTIPLE MYELOMA CELLS 9
Compositions, Kits, and Methods for identification, assessment, prevention, and therapy of cancer 9
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias 9
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 8
Correction of ß-thalassemia major by gene transfer in hematopoietic progenitors of pediatric patients 8
Highly similar genomic landscapes in monoclonal b-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations 8
Multiple reciprocal translocations in salivary gland mucoepidermoid carcinomas 8
Spectral karyotyping combined with locus-specific FISH simultaneously defines genes and chromosomes involved in chromosomal translocations. 8
Up-regulation of c-Jun contributes to induction of apoptosis by Adaphostin in human multiple myeloma cells 8
Targeting proteinkinase C alters ER-stress and b-catenin signaling in multiple myeloma: Therapeutic implications 8
Loss of the Histone Demethylase UTX Contributes to Multiple Myeloma and Sensitizes Cells to EZH2 Inhibitors 8
The AP-1 transcription factor JunB promotes multiple myeloma cell proliferation, survival and drug resistance in the bone marrow microenvironment 8
Telomere dysfunction induces metabolic and mitochondrial compromise. 8
Correlating array CGH with gene expression and sensitivity to drugs in a panel of 60 human cancer cell lines 8
Spectral karyotyping (SKY) in combination with locus-specific FISH, a technique to simultaneously define genes and chromosomes involved in chromosomal translocations 8
Lentiviral Vector-Based Insertional Mutagenesis Identifies New Oncogenes and Molecular Networks That Control Hepatocyte Transformation and Metabolism 8
Stable karyotypes in epithelial cancer cell lines despite high rates of ongoing structural and numerical chromosomal instability 8
Novel Therapeutic Targets in Multiple Myeloma 8
Novel structurally altered P(2X1) receptor is preferentially activated by adenosine diphosphate in platelets and megakaryocytic cells. 8
Molecular Pathogenesis of Multiple Myeloma 8
EXPLOITING IRON TOXICITY IN MULTIPLE MYELOMA: A STRATEGY TO INCREASE THE EFFICACY OF PROTEASOME INHIBITION THERAPIES 8
The small-molecule VEGF-receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma 8
The Tyrophostin Adaphostin (Nsc680410) Inhibits Multiple Myeloma Bone Marrow Angiogenesis In In Vitro And In Vivo 8
β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer 7
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020 7
MUTATIONAL SPECTRUM OF BRAF, NRAS AND KRAS IN MULTIPLE MYELOMA 7
The AP-1 Transcription Factor JunB Promotes Multiple Myeloma (MM) Cell Proliferation, Survival and Drug Resistance in the Bone Marrow Microenvironment 7
Targeting PKC: A Novel Role for Beta-catenin in ER Stress and Apoptotic Signaling 7
Upregulation of c-Jun induces cell death via caspase- triggered c-Abl cleavage in human multiple myeloma 7
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients 7
From oncogene to network addiction: the new frontier of cancer genomics and therapeutics. 7
KMD6A/UTX loss enhances the malignant phenotype of multiple myeloma and sensitizes cells to EZH2 inhibition 7
Common and Contrasting Genomic Profiles Among The Major Human Lung Cancer Subtypes. 7
CS1 Promotes Multiple Myeloma Cell Adhesion, Clonogenic Growth, and Tumorigenicity via c-Maf Mediation 7
Totale 1.120
Categoria #
all - tutte 28.312
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.312


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 6 0 0 0 0 0 0 0 0 0 0 0
2020/202111 0 0 0 1 1 4 5 0 0 0 0 0
2021/2022158 0 0 0 12 2 0 2 123 2 11 1 5
2022/2023809 291 181 31 7 48 114 34 60 15 8 13 7
2023/2024440 10 14 48 126 32 53 15 30 1 25 23 63
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 1.438